Physician perception and recommendation of insulin pens for patients with type 2 diabetes mellitus

Current Medical Research and Opinion

Volumn 24, Issue 8, 2008, Pages 2413-2422

  Peyrot, Mark ^a,b   Rubin, Richard R ^b  

^a LOYOLA UNIVERSITY MARYLAND   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Health services research; Insulin delivery systems; Physician prescribing; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; INSULIN;

BLOOD GLUCOSE MONITORING; CLINICAL PRACTICE; CONTROLLED STUDY; COST CONTROL; CROSS-SECTIONAL STUDY; DRUG COST; DRUG DELIVERY SYSTEM; DRUG EFFICACY; HUMAN; MEDICAL SPECIALIST; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COUNSELING; PHYSICIAN; PHYSICIAN ATTITUDE; POLYPHARMACY; PRIMARY MEDICAL CARE; QUESTIONNAIRE; REVIEW; SELF CARE; SELF REPORT;

CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; EQUIPMENT AND SUPPLIES; HUMANS; INJECTIONS, INTRAMUSCULAR; INSULIN; PHYSICIAN'S PRACTICE PATTERNS;

EID: 50149104154     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/03007990802278644     Document Type: Review

References (28)

1. Nathan DM, Buse JB, Davidson MB, et al. Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2006;29:1963-72
2. Grant RW, Wexler DJ, Watson AJ, et al. How doctors choose medications to treat type 2 diabetes: a national survey of specialists and academic generalists. Diabetes Care 2007;30:1448-53
3. Peyrot M, Rubin R, Lauritzen T, et al. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care 2005;28:2673-9
4. Rubin RR, Peyrot M. Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/ soluble aspart) versus alternative treatment strategies. Diabetes Care 2004;27:2495-7
5. Stocki K, Ory C, Vanderplas A, et al. An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe. Curr Med Res Opin 2007;23:133-46
6. Summers KH, Szeinbach SL, Lenox SM. Preference for insulin delivery systems among current insulin users and nonusers. Clin Ther 2004;9:1498-505
7. Kortykowski M, Bell D, Jacobsen C, et al. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injections in patients with type 1 or 2 diabetes mellitus. Clin Ther 2003;11:2836-48
8. Lee WC, Balu S, Cobden D, et al. Medication adherence an associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed claims data. Clin Ther 2006;28:1712-25
9. Shelmet J, Schwartz S, Cappleman J, et al. Preference and resource utilization in elderly patients: Innolet vs. vial/syringe. Diabetes Res Clin Practice 2004;1:27-35
10. Bohannon NJ, Ohannesian JP, Burdan AL, et al. Patient and physician satisfaction with the Humulin./Humalog Pen, a new 3.O mL prefilled pen device for insulin delivery. Clin Ther 2000;22:1049-67
11. Segal R, Helper CD. Drug choice as a problem-solving process. Med Care 1985;23:967-6
12. Larme AC, Pugh JA. Attitudes of primary care providers toward diabetes: barriers to guideline implementation. Diabetes Care 1998;21:1391-6
13. Rubin RR, Peyrot M. Factors affecting use of insulin pens by patients with type 2 diabetes. Diabetes Care 2008;31:430-2
14. Glickman L, Bruce EA, Caro FG, et al. Physicians' knowledge of drug costs for the elderly. J Am Geriatrics Soc 1994;42:992-6
15. Buchsbaum DG, Clancy CM, Centor RM, et al. House officer attitudes, beliefs, and recording behavior associated with prescribing minor tranquilizers. Teaching Learning Med 1990; 2:30-3
16. Turk DC, Okifugi A. What factors affect physicians' decisions to prescribe opioids for chronic noncancer pain patients? Clin J Pain 1997;13:330-6
17. Paredes P, De la Pena M, Flores-Guerra E, et al. Factors influencing physicians' prescribing behavior in the treatment of childhood diarrhoea: knowledge may not be the clue. Soc Sci Med 1996;42:1141-53
18. Larue F, Colleau. SM, Fontaine A, et al. Oncologists and primary care physicians' attitudes toward pain control and morphine prescribing in France. Cancer 1995;76:2375-82
19. Isacsson G, Bergman U, Wasserman D, et al. The use of antidepressants and therapeutic drug monitoring by general practitioners and psychiatrists: findings from a questionnaire survey in two Swedish areas. Ann Clin Psychiatry 1996;8:153-60
20. Cormack MA, Howells E. Factors linked to the prescribing of benzodiazepines by general practice principals and trainees. Fam Practice 1992;9:466-71
21. Virji A, Britten N. A study of the relationship between patients' attitudes and doctors' prescribing. Fam Practice 1991;8:314-9
22. Hadsall RS, Freeman RA, Norwood GJ. Factors related to the prescribing of selected psychotropic drugs by primary care physicians. Soc Sci Med 1982;16:1747-56
23. Peyrot M, Rubin RR. Validity and reliability of an instrument for assessing health-related quality of life and treatment preferences: The Insulin Delivery System Rating Questionnaire. Diabetes Care 2005;28:53-8
24. Wanberg CR, Banas JT. Predictors of outcomes and openness to changes in a reorganizing workplace. J Applied Psychol 2000; 85:132-42
25. de Costa S, Brackenridge B, Hicks D. A comparison of insulin pen usage in the United States and the United Kingdom. Diabetes Educ 2002;28:52-60
26. Bull SA, Hu H, Hunkeler EM, et al. Discontinuation of use and switching of antidepressants: influence of patient-physician communication. J Am Med Assoc 2002;288:1403-9
27. Robinson W. Ecological correlations and the behavior of individuals. Am Soc Rev 1950;15:351-7
28. Pawaskar MD, Camancho FT, Anderson RT, et al. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis. Clin Ther 2007; 29:1294-305